Supernus Pharmaceuticals, Inc.
Modified release preparations containing oxcarbazepine and derivatives thereof
Last updated:
Abstract:
Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
23 Apr 2021
Issue date:
9 Nov 2021